Thrombus composition and its implication in ischemic stroke assessment and revascularization treatments

Introduction: Since mechanical thrombectomy has allowed ischaemic stroke thrombus retrieval, the exhaustive study of this material has enabled better understanding of the potential physiopathological processes involved in thrombus formation. Development: Thrombotic pathways involved in the different...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan Marta-Enguita, Florencio J.D. Machado, Josune Orbe, Roberto Muñoz
Format: Article
Language:English
Published: Elsevier España 2025-01-01
Series:Neurología (English Edition)
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2173580824000865
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586273945026560
author Juan Marta-Enguita
Florencio J.D. Machado
Josune Orbe
Roberto Muñoz
author_facet Juan Marta-Enguita
Florencio J.D. Machado
Josune Orbe
Roberto Muñoz
author_sort Juan Marta-Enguita
collection DOAJ
description Introduction: Since mechanical thrombectomy has allowed ischaemic stroke thrombus retrieval, the exhaustive study of this material has enabled better understanding of the potential physiopathological processes involved in thrombus formation. Development: Thrombotic pathways involved in the different vascular beds share common mechanisms, causing difficulties in the identification of specific patterns associated with stroke aetiology. However, other factors such as clot formation time, associated inflammatory status, or activation of additional immune and coagulation pathways (neutrophil extracellular trap [NET] delivery, platelet aggregation, endothelial activation, and von Willebrand Factor release) have been described as determinants in thrombus characteristics. Thus, variable proportions of fibrin-/platelet-rich and erythrocyte-rich areas are closely interrelated within the thrombus, frequently associated with a protective outer shell with high concentrations of fibrin, NETs, and von Willebrand Factor. The presence of these components, as well as their distribution and interrelationships, have been shown to have effects on the thrombus’ resistance to revascularisation treatments. Understanding of these pathways has enabled the development of adjuvant therapies capable of enhancing current fibrinolytic drugs and/or increasing the efficacy of endovascular treatments. Conclusion: Understanding of thrombus components and mechanisms involved in thrombus formation represent a potential pathway for the development of ischaemic stroke therapeutics with promising perspectives. Resumen: Introducción: La obtención del material trombótico en el ictus isquémico desde la generalización de la trombectomía mecánica ha permitido un estudio exhaustivo del mismo y de los posibles mecanismos fisiopatológicos subyacentes a su formación. Desarrollo: Los mecanismos trombóticos implicados en los diferentes lechos vasculares no difieren en exceso, condicionando una heterogeneidad importante que ha dificultado la identificación de patrones asociados al origen o etiología del ictus. Se ha observado sin embargo una mayor influencia de factores como el tiempo de desarrollo del coágulo, el estado inflamatorio sistémico o la activación de vías inmunes y de la coagulación [liberación de Neutrophil extracellular traps (NETs), agregación plaquetar, activación endotelial y liberación de Factor de vonWillebrand]. Como resultado, en el seno del trombo conviven en proporciones variables áreas ricas en eritrocitos y áreas ricas en plaquetas/fibrina con una íntima relación entre ellas y acompañadas con frecuencia de una coraza protectora con alto contenido en fibrina, Factor vonWillebrand y NETs. La presencia de estos componentes, así como su disposición e interrelación ha demostrado tener efectos en la resistencia a los diferentes tratamientos revascularizadores. El conocimiento de estas vías ha permitido el desarrollo de posibles terapias adyuvantes con capacidad de potenciar los tratamientos fibrinolíticos actuales y/o aumentar la eficacia del tratamiento endovascular. Conclusión: El conocimiento de los componentes del trombo y los posibles mecanismos implicados en su formación es una potencial vía de desarrollo en el tratamiento del ictus isquémico con resultados prometedores.
format Article
id doaj-art-7e6f6d5b75a64666b8d2f68013e77cb0
institution Kabale University
issn 2173-5808
language English
publishDate 2025-01-01
publisher Elsevier España
record_format Article
series Neurología (English Edition)
spelling doaj-art-7e6f6d5b75a64666b8d2f68013e77cb02025-01-26T05:03:46ZengElsevier EspañaNeurología (English Edition)2173-58082025-01-014017788Thrombus composition and its implication in ischemic stroke assessment and revascularization treatmentsJuan Marta-Enguita0Florencio J.D. Machado1Josune Orbe2Roberto Muñoz3Servicio de Neurología, Hospital Universitario Navarra, Pamplona, Navarra, Spain; Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, Spain; Laboratorio Aterotrombosis, CIMA-Universidad de Navarra, IdiSNA, Pamplona, Navarra, Spain; RICORS-ICTUS, ISCIII, Madrid, Spain; Corresponding author.Laboratorio Aterotrombosis, CIMA-Universidad de Navarra, IdiSNA, Pamplona, Navarra, SpainLaboratorio Aterotrombosis, CIMA-Universidad de Navarra, IdiSNA, Pamplona, Navarra, Spain; RICORS-ICTUS, ISCIII, Madrid, SpainServicio de Neurología, Hospital Universitario Navarra, Pamplona, Navarra, Spain; RICORS-ICTUS, ISCIII, Madrid, SpainIntroduction: Since mechanical thrombectomy has allowed ischaemic stroke thrombus retrieval, the exhaustive study of this material has enabled better understanding of the potential physiopathological processes involved in thrombus formation. Development: Thrombotic pathways involved in the different vascular beds share common mechanisms, causing difficulties in the identification of specific patterns associated with stroke aetiology. However, other factors such as clot formation time, associated inflammatory status, or activation of additional immune and coagulation pathways (neutrophil extracellular trap [NET] delivery, platelet aggregation, endothelial activation, and von Willebrand Factor release) have been described as determinants in thrombus characteristics. Thus, variable proportions of fibrin-/platelet-rich and erythrocyte-rich areas are closely interrelated within the thrombus, frequently associated with a protective outer shell with high concentrations of fibrin, NETs, and von Willebrand Factor. The presence of these components, as well as their distribution and interrelationships, have been shown to have effects on the thrombus’ resistance to revascularisation treatments. Understanding of these pathways has enabled the development of adjuvant therapies capable of enhancing current fibrinolytic drugs and/or increasing the efficacy of endovascular treatments. Conclusion: Understanding of thrombus components and mechanisms involved in thrombus formation represent a potential pathway for the development of ischaemic stroke therapeutics with promising perspectives. Resumen: Introducción: La obtención del material trombótico en el ictus isquémico desde la generalización de la trombectomía mecánica ha permitido un estudio exhaustivo del mismo y de los posibles mecanismos fisiopatológicos subyacentes a su formación. Desarrollo: Los mecanismos trombóticos implicados en los diferentes lechos vasculares no difieren en exceso, condicionando una heterogeneidad importante que ha dificultado la identificación de patrones asociados al origen o etiología del ictus. Se ha observado sin embargo una mayor influencia de factores como el tiempo de desarrollo del coágulo, el estado inflamatorio sistémico o la activación de vías inmunes y de la coagulación [liberación de Neutrophil extracellular traps (NETs), agregación plaquetar, activación endotelial y liberación de Factor de vonWillebrand]. Como resultado, en el seno del trombo conviven en proporciones variables áreas ricas en eritrocitos y áreas ricas en plaquetas/fibrina con una íntima relación entre ellas y acompañadas con frecuencia de una coraza protectora con alto contenido en fibrina, Factor vonWillebrand y NETs. La presencia de estos componentes, así como su disposición e interrelación ha demostrado tener efectos en la resistencia a los diferentes tratamientos revascularizadores. El conocimiento de estas vías ha permitido el desarrollo de posibles terapias adyuvantes con capacidad de potenciar los tratamientos fibrinolíticos actuales y/o aumentar la eficacia del tratamiento endovascular. Conclusión: El conocimiento de los componentes del trombo y los posibles mecanismos implicados en su formación es una potencial vía de desarrollo en el tratamiento del ictus isquémico con resultados prometedores.http://www.sciencedirect.com/science/article/pii/S2173580824000865IctusTromboFibrinolisisNeutrophil extracellular trapsCoagulación
spellingShingle Juan Marta-Enguita
Florencio J.D. Machado
Josune Orbe
Roberto Muñoz
Thrombus composition and its implication in ischemic stroke assessment and revascularization treatments
Neurología (English Edition)
Ictus
Trombo
Fibrinolisis
Neutrophil extracellular traps
Coagulación
title Thrombus composition and its implication in ischemic stroke assessment and revascularization treatments
title_full Thrombus composition and its implication in ischemic stroke assessment and revascularization treatments
title_fullStr Thrombus composition and its implication in ischemic stroke assessment and revascularization treatments
title_full_unstemmed Thrombus composition and its implication in ischemic stroke assessment and revascularization treatments
title_short Thrombus composition and its implication in ischemic stroke assessment and revascularization treatments
title_sort thrombus composition and its implication in ischemic stroke assessment and revascularization treatments
topic Ictus
Trombo
Fibrinolisis
Neutrophil extracellular traps
Coagulación
url http://www.sciencedirect.com/science/article/pii/S2173580824000865
work_keys_str_mv AT juanmartaenguita thrombuscompositionanditsimplicationinischemicstrokeassessmentandrevascularizationtreatments
AT florenciojdmachado thrombuscompositionanditsimplicationinischemicstrokeassessmentandrevascularizationtreatments
AT josuneorbe thrombuscompositionanditsimplicationinischemicstrokeassessmentandrevascularizationtreatments
AT robertomunoz thrombuscompositionanditsimplicationinischemicstrokeassessmentandrevascularizationtreatments